Akili, a digital therapeutics company, agreed to merge with Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games. Financial terms were not disclosed. “In today’s global mental health crisis, patients deserve access to clinically validated solutions that address their specific needs. We have been able to advance multiple solutions on our platform since founding Virtual Therapeutics, and we look forward to taking a significant step forward through this merger. The team at Akili has been successful in applying clinical and scientific rigor to bring new products forward, and we believe their expertise will complement our efforts. Together, we can build a company that brings these behavioral services to as many patients as possible – regardless of where they are or barriers that exist for them today,” Dan Elenbaas, Virtual Therapeutics Co-Founder and CEO.